期刊文献+

DC-SIGN固有免疫调节及其表达调控机制研究进展 被引量:2

Research progress on DC-SIGN medicated innate immunoregulation and regulatory mechanism of its expression
原文传递
导出
摘要 DC-SIGN(DC-specific ICAM-3-grabbing non integrin,CD209)系C型凝集素家族主要成员,具有模式识别受体和介导细胞黏附功能。DC-SIGN可通过分子中凝集素糖识别域,识别多种病原体的外源性和机体内源性抗原以及细胞表面黏附分子(ICAM-2,3)中甘露糖或岩藻糖的糖基团,并对话协调Toll样受体等,介导树突状细胞(DC)等参与病原体或肿瘤细胞的免疫逃逸;也可调节DC黏附迁移并在炎症启动中激活初始T细胞免疫应答。因而,作为天然免疫分子介导基础,DC-SIGN在DC参与的感染性和炎症性疾病等的正负免疫调节中发挥了关键作用。目前有关DC-SIGN免疫调节效应涉及的信号转导以及分子表达调控机制尚未完全阐明,就相关进展作一综述。 DC-SIGN (dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin) belongs to the major members of C-type lectin family, which is a PRR (pattern recognition receptor) and can mediate cell adhesion. DC-SIGN can specifically recognize glycoconjugates containing mannose or fucose in various exogenous antigen of pathogens, endogenous self-antigen and intercellular adhesion molecule 2,3 (ICAM-2, 3) by its lectin carbohydrate recognition domain. Moreover, it is also involved in immune escape of tumor cell or pathogens mediated by dendritic cells (DCs) through cross-talking with Toll like receptors. In the initial response of inflammation, DC-SIGN modulates the adhesion and migration of DCs to activate naive T-cell. Therefore, as an innate immune molecule, DC-SIGN plays an crucial role in infectious and inflammatory diseases through its positive and negative immunoregulatory effects on DCs. However, the immunoregulation mechanisms of DC-SIGN including signal transduction and expression regulation have not been fully elucidated. We have reviewed some progress in this field here.
出处 《生命科学》 CSCD 2012年第10期1075-1081,共7页 Chinese Bulletin of Life Sciences
基金 国家自然科学基金项目(81070567 8100-0163 81170383 81270801)
关键词 DC-SIGN 免疫调节 信号转导 表达机制 DC-SIGN immunoregulation signal transduction expression mechanism
  • 相关文献

参考文献5

二级参考文献55

  • 1Tong Zhou,Yongxi Chen,Li Hao,Yanyun Zhang.DC-SIGN and Immunoregulation[J].Cellular & Molecular Immunology,2006,3(4):279-283. 被引量:11
  • 2Hitoshi Asakura,Kenji Suzuki,Terasu Honma.Recent advances in basic and clinical aspects of inflammatory bowel disease: Which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease?[J].World Journal of Gastroenterology,2007,13(15):2145-2149. 被引量:5
  • 3Mac Donald AS. 'RAPAMUNE global study group. A world- wide, phase HI , randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal al lografts[J]. Transplantation, 2001,71 : 271-280.
  • 4Li H, Pauza CD. Rapamycin increases the yield and eiffector function of human yδT cells stimulated in vitro[J] Cancer Immunol Immunother. 2011,60:361 370.
  • 5Monti P , Mercalli A , Leone BE, et al. Rapamycin impairs antigen uptake of human dendritic cells[J]. Transplantation, 2003,75:137-145.
  • 6Hackstein H, Taner T, Zahorchak AF, et al. Rapamycin in hibits II. 4 induced dendritic cell maturation in vitro and den dritic cell mobilization and function in vivo[J]. Blood, 2003 101,4457-4463.
  • 7von Bubnoff D, Geiger E, Bieber T. Antigen presenting cells in allergy[J]. J Allergy Clin Immunol, 2001,108=329 339.
  • 8Lipscomb MF, Masten BJ. Dendritic celis: immune regula tots in health and disease[J]. Physiol Rev, 2002,82.. 97-130.
  • 9Steinman RM, Hawiger D, Liu K, et al. Dendritic cell function in vivo during the steady state: a role in peripheral tolerance[J]. Ann NY Acad Sci, 2003,987:15:25.
  • 10Banchereau J, Briere F, Caux C, et al. lmmunobiology of dendritic cells[J]. Annu Rev Immunol, 2000,18 : 767-811.

共引文献27

同被引文献10

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部